Anti-LewisX [28]
Invented by Prof Nancy Hogg from Cancer Research UK London Research Institute: Lincoln's Inn Fields
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (4)
- Inventor Info
Info
Catalogue Number | 151041 |
Applications | FACS IHC IP |
Antigen/Gene or Protein Targets | Lewis X (CD15) |
Synonyms | Fucosyltransferase 4; Galactoside 3-L-Fucosyltransferase; ELAM-1 Ligand Fucosyltransferase; FUC-TIV; FCT3A; ELFT; Stage-Specific Embryonic Antigen; Alpha (1,3) Fucosyltransferase; EC 2.4.1.65; Lewis X; SSEA-1; FUTIV; CD15; LeX |
Reactivity | Human |
Relevance | Lewis X (CD15) is a branched pentasaccharide found on neutrophils, eosinophils and monocytes. Lewis X is distributed abnormally in myeloid leukeamias and is commonly used in the diagnosis of Hodgkin’s disease. It can also be used for analysis of myeloid leukaemias and studies of myeloid differentiation. |
Host | Mouse |
Immunogen | Monocytes, separated from other peripheral blood leucocytes (PBL) on fibronectin plates. |
Subclass | IgM |
Molecular Weight (kDa) | 83 |
Myeloma Used | Sp2/0-Ag14 |
Recommended Growing Conditions | DMEM + 5% FCS |
Strain | Balb/c |
Notes | Clone 28 does not activate complement. |
Research Area | Cancer, Immunology |
References: 4 entries
Hogg et al. 1984. Immunology. 53(4):753-67. PMID: 6389324.
IHC IP
Monoclonal antibodies specific for human monocytes, granulocytes and endothelium.
Europe PMC ID: 6389324
Linch et al. 1984. Blood. 63(3):566-73. PMID: 6365201.
Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML.
Europe PMC ID: 6365201
Add a reference
References: 4 entries
Hogg et al. 1984. Immunology. 53(4):753-67. PMID: 6389324.
IHC IP
Monoclonal antibodies specific for human monocytes, granulocytes and endothelium.
Linch et al. 1984. Blood. 63(3):566-73. PMID: 6365201.
Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML.
Add a reference